BACKGROUND: The family of uncoupling proteins is thought to play an important role in the regulation of energy metabolism by uncoupling the respiratory chain reactions from ATP synthesis. The recently discovered uncoupling protein 2 (UCP2) is upregulated in genetically obese rodent models and during long term high fat feeding. AIM: We have examined the UCP2 mRNA levels in liver, heart and white adipose tissue (WAT) of obese ventromedial hypothalamus (VMH)-lesioned rats, during the dynamic and the early stage of the static phase of obesity, before the appearance of most of the metabolic perturbations associated with long term established obesity. RESULTS: The amount of UCP2 mRNA was not increased in any tissue of VMH-lesioned rats relative to control animals during the dynamic phase nor during the early static phase of obesity. CONCLUSION: These results indicate that in the rat, obesity does not necessarily lead to an increase in UCP2 expression and suggest that the up-regulation of UCP2 described in other models may be secondary to metabolic perturbations, rather than to a direct adaptative response to the increased adipose tissue content of the organism.
Introduction
The recently cloned uncoupling protein 2 (UCP2) protein belongs to the family of mitochondrial uncoupling proteins believed to play an important role in nonshivering thermogenesis and the disposal of excess caloric energy by dissipating the proton gradient across the inner mitochondrial membrane. 1 ± 4 In contrast to UCP1 and UCP3, whose expression is restricted to brown adipose tissue (UCP1, UCP3) and skeletal muscle (UCP3), 5, 6 UCP2 is expressed in many tissues in rodents and humans. 3 ± 5 In genetic rodent models of obesity, like the obaob or dbadb mouse, UCP2 expression is up-regulated. 4 Long-term feeding with a high-fat diet increases UCP2 expression in different mouse strains. 3 In humans, a positive correlation has been reported between UCP2 expression in adipose tissue and body mass index (BMI). 7 These ®ndings suggest that obesity in different species might be associated with increases in UPC2 expression. Upregulation of UCP2 expression could therefore act to limit adiposity, as suggested for UCP1 in rats, where a hypercaloric diet can induce thermogenesis in brown adipose tissue (BAT). 8 However, the animal models used in these studies are characterized by metabolic and endocrinological perturbations, ranging from insulin resistance and high plasma concentrations of non-esteri®ed fatty acids (NEFA) in high fat-fed rodents 9, 10 to overt diabetes in obaob and dbadb mice. 11 In humans too, obesity is generally associated with insulin resistance and increased plasma NEFA. 12 Therefore, it is unknown whether adiposity directly increases UCP2 expression or whether the up-regulation of UCP2 is an effect secondary to the perturbations associated with obesity. The hypothalamic model of obesity allows the study of animals at the very beginning of obesity, well before the appearance of insulin resistance and its associated metabolic perturbations. 13 In this study, we sequenced the rat UCP2 gene and measured UCP2 mRNA expression in various tissues of obese ventromedial hypothalamus (VMH)-lesioned rats during the dynamic phase of weight gain and the beginning of the static phase of obesity.
Materials and methods

Chemicals
All chemicals were purchased from Sigma Aldrich (St Quentin, Fallavier, France), except for formamide (Prolabo, Paris, France), Hyper®lms MP and nyloǹ hybond-N' membranes (Amersham, Les Ulis, France). PCR-primers were from Life Technologies, Cergy Pontoise, France.
Animals
Female Wistar rats (IFA Credo, L'Arbresles, France) weighing 200±220 g were housed in to animal facility with light period from 07.00±19.00 h and had free access to water and laboratory chow. Rats were anaesthetized intraperitoneally with 95 mg ketamineakg body weight (Imalgene 500, Bio-Me Ârieux, France) and VMH lesions were carried out as described previously. 14, 15 For the determination of blood glucose, plasma insulin and plasma lipids, a catheter was implanted into the carotid artery as previously described.
14 Blood samples were taken one, two and ®ve weeks after the lesion, in order to determine blood glucose, plasma insulin, triglycerides and non-esteri®ed fatty acids (NEFA) from control and VMH-rats. Tissues were isolated one or six weeks after the lesion. Control and VMH rats were killed by cervical dislocation. Liver, periovarian and retroperitoneal white adipose tissue (WAT), and heart were rapidly removed, frozen in liquid nitrogen and stored at -80 C. Blood glucose was determined by a glucose oxidase kit (Boehringer, Meylan, France). Plasma insulin was measured by radioimmunoassay (RIA) (SON BIOMEDICAL) with rat insulin as a standard. Plasma NEFA were determined by an enzymatic colorimetric assay (NEFA C, WAKO chemicals, Dardilly, France) and plasma triglycerides by hydrolysis with lipoprotein lipase and enzymatic measurement of glycerol.
Preparation of total cellular RNA Total RNA was extracted from 500 mg WAT, liver or heart using the guanidine thiocyanate method and the RNA solution was stored at 780 C. The concentration of RNA was determined by measuring the absorbance at 260 nm. All samples had an A260aA280 ratio of about 1.8±2.0.
Sequencing of the coding region of the rat UCP2 gene
Total RNA from rat WAT was reverse-transcribed and used as a template for PCR with a nested set of ten primer pairs. These primers were derived from the mouse UCP2 mRNA sequence and spanned the entire coding region of the mouse UCP2 mRNA. The PCR products obtained with these primers were analyzed on 2% agarose gels, extracted from the gels using the QIAEXII extraction kit (Qiagen, Courtaboeuf, France) and sequenced in both directions. The Genbank accession number for the rat UCP2 coding sequence is AF039033.
Northern blotting
Total RNA (20 mg) was denatured by heating at 95 C for 2 min in 2.2 mM formaldehyde and 50% (volavol) formamide, and separated by electrophoresis in 1% agarose gel for 16±18 h at 60 V and then transferred onto a nylon membrane (Hybond N, Amersham). Blots were hybridized with a 281 bp rat-speci®c UCP2 probe generated by RT-PCR of rat total RNA. The upstream primer was 5
H -TGTGCTGAGCTGGT-GACCTATGAC and annealed with its 5 H end to position 571 of the rat UCP2 open reading frame, the downstream primer was 5
H -TTCCAGGAACC-CAAGCGGAGAAAG and annealed with its 5 H end to position 851. The probe was labelled with a-32 P dCTP (ICN, Orsay, France) to a speci®c activity of 1 Â 10 8 dpmamg using a NonaPriming kit (Oncor Appligene, Illkirch, France). After 5 h prehybridization at 42 C in hybridization buffer (40% formamide, 9% dextran sulfate, 0.2% BSA, 0.2% polyvinyl pyrrolidone, 0.2% ®coll, 0.1% sodium pyrophosphate, 0.01% SDS, 4 mM Tris, 0.9 M NaCl with 0.1 mgaml salmon sperm DNA), the membranes were hybridized with the labeled probe overnight at 42 C in hybridization buffer. The blots were exposed for 5±10 d at 7 80 C with intensifying screens. Quanti®cation was performed by densitometric scanning.
Statistical analysis
Results are expressed as mean s.e.m. Statistical analysis was performed by student's t-test for paired data.
Results
Sequencing of the rat UCP2 gene coding regions
In order to obtain the nucleotide sequence of the coding region of the rat UCP2 protein, reverse-transcribed total RNA from rat WAT was ampli®ed with different sets of mouse UCP2-speci®c primers. Sequencing of these RT-PCR products revealed that the rat UCP2 mRNA codes for an open reading frame of 309 amino acids and that the protein derived from the mRNA sequence differs only in three positions from its mouse UCP2 homologue: an Ala substitutes for a Val in codon 51, a Thr for an Ala at position 192, in the putative fourth transmembrane domain, and a Glu for a Gln at position 303, in the C-terminus Figure 1 Uncoupling protein 2 (UCP2) expression in various rat tissues. WAT white adipose tissue; po periovarian WAT; re retroperitoneal WAT. The expression pattern of UCP2 mRNA in rat tissues was assessed by Northern blotting (Figure 1) . The PCR-generated rat speci®c UCP2 probe hybridizes to a 1.6 kb RNA that migrates below the 18S rRNA. In liver, UCP2 mRNA is barely detectable even when autoradiography was carried out up to 21 d. The strongest UCP2 signal is seen in heart, followed by WAT (periovarian and retroperitoneal WAT depots) and liver. This con®rms the tissue distribution of rat UCP2 mRNA found in three studies. 5, 16, 17 Humans also have higher UCP2 levels in the heart than in the liver. 6, 17 Similar results have been obtained in mice.
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Weight gain of VMH-rats and metabolic parameters
At the time of the lesion, the mean body weight was 237AE 7 g (n 4) for the control rats and 244AE 5 g (n 5) for the lesioned animals. The lesioned rats became instantly hyperphagic and after six weeks of ad libitum laboratory chow feeding, they weighed 410AE 23 g vs 288AE 6 g for the controls. The VMHrats thus nearly doubled their pre-operative body weight during the six weeks following the lesion. During the ®rst week following the lesion, the average weight gain of the VMH-rats was 55AE 12 g compared to 12 AE 1 g for the controls. This corresponds to the dynamic phase of obesity, when the weight gain per unit of time is greatest. Between the ®fth and the sixth week following the lesion, the obese VMH-rats gained only 13AE 3 g on average (controls: average weight gain 7 AE 3 g). Therefore, ®ve weeks after the lesion, the rate of weight gain became considerably slower and the obesity entered its static phase. The concentration of plasma insulin and several key metabolites at different time points after the lesion are summarized in Table 1 . Up to ®ve weeks after the lesion, the VMH-rats did not become hyperglycaemic. Hyperinsulinaemia was observed at all time points tested. This is a well known characteristic of VMH rats, in which insulin levels rise almost instantly after the lesion, because of the increased parasympathetic and the decreased sympathetic activities. 18, 19 In contrast, plasma NEFA levels were not signi®cantly different in control and VMH-rats at any time point studied. Plasma triglycerides became slightly elevated in VMH rats only ®ve weeks after the lesion.
UCP2 expression in different tissues of VMH-lesioned rats during the development of obesity Total RNA was prepared from different tissues of VMH-lesioned rats during the dynamic phase of weight gain, one week after the lesion (Figure 2 ) and after establishment of obesity, six weeks after VMH-lesion (Figure 3 ). These RNA samples were hybridized after Northern blotting with a 281 bp ratspeci®c UCP2 probe. As controls for equal gel loading, the signals of 18 S rRNA are also shown. The hybridization signals were quantitated by densitometric scanning and normalized to the 18 S rRNA signals. No signi®cant differences in UCP2 expression were found in the heart (n 4, P b 0.464), periovarian white adipose tissue (n 7, P b 0.471) and retroperitoneal WAT (n 3, P b 0.088) one week after the lesion. Six weeks after the lesion, UCP2 mRNA expression remained similar in control and VMH rats in heart (n 8, P b 0.562), periovarian WAT (n 4, P b 0.542) and retroperitoneal WAT (n 6, P b 0.122). Thus, UCP2 expression is not up-regulated during the establishment of hypothalamic obesity.
Discussion
The family of uncoupling proteins is thought to be implicated in the regulation of energy metabolism. In a mouse strain that is resistant to diet-induced obesity, increased UCP2 expression is observed. It is suggested that UCP1 is responsible for diet-induced thermogenesis in BAT, 8 and UCP2 may be another line of defense against diet-induced obesity. Indeed, UCP2 mRNA is upregulated in several models of obesity. 3, 4, 7 It is thus conceivable that a signal re¯ect-ing the size of the adipose tissue somehow triggers the upregulation of UCP2. Statistically signi®cant differences between VMH-rats and control animals are indicated by *P`0.05 or **P`0.001. NEFA non-esteri®ed fatty acids.
UCP2 expression in VMH-rats A Strobel et al Figure 4 . b) Densitometric analysis of UCP2 expression in tissues of control rats and VMH-lesioned rats. Results are shown as the mean AE s.e.m. Four to eight independent experiments were carried out. In all cases, P b 0.122. UCP2 mRNA in liver was barely detectable and therefore not quanti®ed.
UCP2 expression in VMH-rats A Strobel et al
Leptin, the adipose tissue-derived satiety hormone that suppresses eating and increases energy expenditure, would be a good candidate to link adipose mass and UCP2 expression. In rats rendered hyperleptinaemic by adenoviral leptin gene therapy, the expression of UCP2 in various peripheral tissues is increased. 20 Furthermore, leptin was shown in vitro to directly induce UCP2 expression in isolated rat white adipocytes. 20 However, such a direct mechanism does not appear to be operative in VMH-lesioned rats, in spite of elevated leptin levels in the animals. Indeed, the obese VMH-lesioned rats display 2±9-fold elevated leptin mRNA levels in adipocytes (see Refs 21 and 22 and our own unshown results) and up to 9-fold increases of plasma leptin. 22 However, UCP2 expression is not upregulated in the adipose tissue, heart and liver of VMH obese rats. Moreover, UCP2 is upregulated in obaob and dbadb mice, 4 in spite of the absence of either leptin in the former or functional OB receptors in brain and periphery in the latter. Finally, UCP2 mRNA is upregulated in rats during fasting, 23 when adipose tissue mass diminishes and leptin levels are decreased. 24 Altogether, these ®ndings do not support a direct role of leptin or adipose mass size in the control of UCP2 expression.
NEFAs or their metabolites could provide a link between obesity and up-regulation of UCP2 through activation of the transcription factors of the PPAR family. PPAR activators have been shown to upregulate UCP2 expression in mouse preadipose and adipose cells 25, 26 and also in immortalized human PAZ6 adipocytes (See Ref. 27 and our own unpublished results). NEFA levels have been reported to be elevated in genetically obese rodents, 11 during longterm high-fat feeding 10 and also in the fasting rat 28 (that is, in situations where up-regulation of UCP2 has been described). We did not ®nd any signi®cant differences in NEFA concentrations between control and VMH rats at one, two or ®ve weeks after the lesion. Therefore, it might be possible that the concentration of important activators of UCP2 expression, such as fatty acids or their metabolites, is too low in VMH-rats to upregulate UCP2 expression. It is also possible that the up-regulation of UCP2 in obesity is species-dependent. It has been shown very recently that UCP2 expression in various tissues of obese Zucker fatty (faafa) rats is not elevated compared to their lean littermates. 16 Therefore obesity does not appear to be necessarily associated with increased UCP2 expression in rats.
